FDA Inspection 1140548 — Eugene B. McLaurin, M.D.
The FDA completed an inspection of Eugene B. McLaurin, M.D. on April 2, 2021 in Memphis, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 2, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Memphis, TN (United States)
Additional Details
Clinical Investigator (CI)